- U.S. Medicines Spending Grew in 2023 as Greater Access Offset COVID-19-related Decline, Says IQVIA Institute
- IQVIA CFO Ron Bruehlman to Speak at the Bank of America Health Care Conference on May 14, 2024
- IQVIA Reports First-Quarter 2024 Results
- IQVIA Celebrates Wendy Stewart and Susan Barnes, Winners of Healthcare Businesswoman's Association Luminary and Rising Star Awards
- IQVIA to Announce First-Quarter 2024 Results on May 2, 2024
- IQVIA and Salesforce Expand Global Partnership to Accelerate the Development of Life Sciences Cloud
- IQVIA Publishes its 2023 Environmental, Social and Governance Report
- Global Biopharma R&D Boasts Increased Funding, Productivity and Product Launches in 2023, says IQVIA Institute Report
- IQVIA CFO Ron Bruehlman to Speak at Citi’s Unplugged Medtech and Life Sciences Access Day on February 29, 2024
More ▼
Key statistics
As of last trade IQVIA Holdings Inc (IQV:NYQ) traded at 228.71, -12.62% below its 52-week high of 261.73, set on Mar 08, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 229.27 |
---|---|
High | 229.59 |
Low | 226.75 |
Bid | 228.66 |
Offer | 228.83 |
Previous close | 230.09 |
Average volume | 827.77k |
---|---|
Shares outstanding | 182.20m |
Free float | 180.12m |
P/E (TTM) | 31.25 |
Market cap | 41.73bn USD |
EPS (TTM) | 7.33 USD |
Data delayed at least 15 minutes, as of May 21 2024 18:38 BST.
More ▼